MODIFICATION TO SYNCHRON LX 20 CLINICAL CHEMISTRY SYSTEM— 510(k) K011213

Substantially Equivalent

Beckman Coulter, Inc.

FDA 510(k) clearance K011213 for MODIFICATION TO SYNCHRON LX 20 CLINICAL CHEMISTRY SYSTEM, Substantially Equivalent on 2001-05-16. Applicant: Beckman Coulter, Inc..

Clearance details

Applicant: Beckman Coulter, Inc.
Product code: Code JGS
Advisory panel: Clinical Chemistry
Date received: 2001-04-20
Decision date: 2001-05-16
Decision: Substantially Equivalent
Clearance type: Special
Location: Brea, CA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code JGS

product code JGS

Malfunction: 535
Total: 535

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.